The specificity of copromotion effects of caffeine with known goitrogenic factors on thyroid carcinogenesis was examined in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Male F344 rats were divided into 8 groups, each consisting of 10 animals, and received a single sc injection of 2,800 mg/kg DHPN. From one week after the DHPN initiation, they were given basal diet, iodine deficiency (ID) diet, 500 ppm phenobarbital (PB) solution or 1,000 ppm sulfadimethoxine (SDM) solution with or without 1,500 ppm caffeine feeding for 12 weeks. The caffeine, PB, SDM, and ID treatments significantly (p < 0.05 or 0.01) increased the relative thyroid weights, and the increases with PB or ID were further (p < 0.05 or 0.01) enhanced in combination with caffeine. SDM drastically promoted thyroid carcinogenesis in association with increased serum TSH levels regardless of the caffeine treatment. Thyroid follicular carcinomas and adenomas were more frequently observed in the additional caffeine groups than in the ID alone groups. The incidence and multiplicity of focal thyroid follicular hyperplasias in the ID-treated groups were significantly (p < 0.05 and 0.01) elevated in the case of combination with caffeine. Increases in serum TSH levels with PB or ID were also further enhanced in combination with caffeine. Serum thyroid hormone levels were significantly (p < 0.01) decreased by SDM but significantly (p < 0.05 or 0.01) increased by caffeine, PB or ID. Our results clearly indicate that dietary caffeine at a high dose of 1,500 ppm interacts with ID, but neither SDM nor PB, to promote rat thyroid carcinogenesis although the combined caffeine + PB treatment somewhat affected thyroid weights as well as thyroid hormone levels.
Abrams, G.M., and Larsen, P.R. (1973). Triiodothyronine and thyroxine in the serum and thyroid glands of iodine-deficient rats. J Clin Invest52, 2522—31.
2.
Bagchi, N., Shivers, B., and Brown, T.R., (1985). Studies on the mechanism of acute inhibition of thyroglobulin hydrolysis by iodine. Acta Endocrinol108, 511—7.
Botts, S., Jokinen, M.P., Isaack, K.R., Meuten, D.J., and Tanaka, N. (1991). Proliferative lesions of the thyroid and parathyroid glands, E-3Guides for Toxicologic Pathology, pp. 1—12. STP/ARP/AFIP. Washington, DC.
5.
Capen, C.C. (1997). Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol25, 39—48.
6.
Clozel, M., Branchaud, C.L., Tannenbaum, G.S., Dussault, J.H., and Aranda, J.V. (1983). Effect of caffeine on thyroid and pituitary function in newborn rats. Pediatr Res17, 592—5.
7.
Davies, D.T. (1993). Assessment of rodent thyroid endocrinology: advantages and pit-fallsComp Hematol Int3, 142—52.
8.
Dere, W.H., and Rapoport, B. (1986). Control of growth in cultured rat thyroid cells . Mol Cell Endocrinol44, 195—9.
9.
Dumont, J.E., Lamy, F., Roger, P., and Maenhaut, C. (1992). Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev72, 667—7.
10.
Ealey, P.A., Ahene, C.A., Emmerson, J.M., and Marshall, N.J. (1987). Forskolin and thyrotrophin stimulation of rat FRTL-5 thyroid cell growth: the role of cyclic AMP. J Endocrinol114, 199—205.
Ikeda, T., Nishikawa, A., Imazawa, T., Kimura, S., and Hirose, M. (2000). Dramatic synergism between excess soybean intake and iodine deficiency on the development of rat thyroid hyperplasia. Carcinogenesis21, 707—13.
15.
Ikeda, T., Nishikawa, A., Son, H-Y., Nakamura, H., Miyauchi, M., Imazawa, T., Kimura, S., and Hirose, M. (2001). Synergistic effects of high-dose soybean intake with iodine deficiency, but not sulfadimethoxine or phenobarbital, on rat thyroid proliferation. Jpn J Cancer Res92, 390—5.
16.
International Agency for Research on Cancer ( 1991). Coffee, tea, meat, methylxanthins and methylglyoxal. IARC Monograph on the Evaluation of Carcinogenic Risk of Chemicals to humans . Suppl. 51. pp. 291—390. IARC Scientific Publications, Lyon, France.
17.
Jin, S., Hornicek, F.J., Neylan, D., Zakarija, M., and McKenzie, J.M. (1986). Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells. Endocrinology119, 802—10.
18.
Kimura, S., Suwa, J., Ito, M., and Sato, H. (1976). Development of malignant goiter by defatted soybean with iodine-free diet in rats. Gann67, 763—5.
19.
Kohn, L.D., Aloj, S.M., Tombaccini, D., Rotella, C.M., Toccafondi, R., Marcocci, C., Corda, D., and Gullman, E.F. (1985). The thyrotropin receptor. Biochemical Actions of Hormones. (G. Litwack) pp. 457—512. Academic Press, New York.
20.
Linos, A., Linos, D.A., Vgotza, N., Souvatzoglou, A., and Koutras, D.A. (1989). Does coffee consumption protect against thyroid disease? Acta Chir Scand155, 317—20.
21.
McClain, R. (1992). Thyroid gland neoplasia: genotoxic mechanisms . Toxicol Lett 64/65, 397—408.
22.
McClain, R.M., Levin, A.A., Posch, R.C., and Downing, J.M. (1989). The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol Appl Phamacol99, 216—28.
23.
McClain, R.M., Posch, R.C., Bosakowski, T., and Armstrong, J.M. (1988). Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital. Toxicol Appl Pharmacol94, 254—65.
24.
Mitsumori, K., Onodera, H., Takahashi, M., Shimo, T., Yasuhara, K., Kitaura, K., Takahashi, M., and Hayashi, Y. (1995). Effect of thyroid stimulating hormone on the development and progression of rat thyroid follicular cell tumors. Cancer Lett92, 193—202.
25.
Mohr, U., Althoff, J., Ketkar, M.B., Conradt, P., and Morgareidge, K. (1984). The influence of caffeine on tumor incidence in Sprague-Dawley rats. Food Chem Toxicol22, 377—82.
26.
Nunez, J., and Pommier, J. (1982). Formation of thyroid hormones. Vitam Horm39, 175—229.
27.
Ohshima, M., and Ward, J.M. (1986). Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats. Cancer Res46, 877—83.
28.
Reeves, P.G., Nielsen, F.G., and Fahey, G.C. (1993). AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr123, 1939—51.
29.
Riesco, G., Taurog, A., Larsen, R., and Krulich, L. (1977). Acute and chronic responses to iodine deficiency in rats. Endocrinology100, 303—13.
30.
Shafer, S.H., Phelps, S.H., and Williams, C.L., (1998). Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors . Biochem Pharmacol56, 1229—36.
31.
Son, H-Y., Nishikawa, A., Ikeda, T., Furukawa, F., and Hirose, M. (2000). Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn J Cancer Res91, 966—72.
32.
Son, H-Y., Nishikawa, A., Kanki, K., Okazaki, K., Kitamura, Y., Lee, K-Y., Umemura, T., and Hirose, M. (2003). Synergistic interaction between excess caffeine and deficient iodine on the promotion of thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine. Cancer Sci94, 334—7.
33.
Stork, P.J., and Schmitt, J.M. (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol12, 258—66.
34.
Takayama, S., and Kuwabara, N. (1982). Long-term study on the effect of caffeine in Wistar rats. Gann73, 365—71.
35.
Tsygankova, O.M., Kupperman, E., Wen, W., and Meinkoth, J.L. (2000). Cyclic AMP activates Ras. Oncogene19, 3609—15.
36.
Van Sande, J., Grenier, G., Willems, C., and Dumont, J.E. (1975). Inhibition by iodide of the activation of the thyroid cyclic 3', 5'-AMP system. Endocrinology96, 781—6.
37.
Villone, G., De Amicis, F., Veneziani, B.M., Salzano, S., Di Carlo, A., and Tramontano, D. (1997). Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. Cell Growth Differ8, 1181—8.
38.
Villone, G., De Vita, G., Chieffi, P., Picascia, A., Stanzione, R., Santoro, M., Fusco, A., and Tramontano, D. (2000). Association between the expression of E1A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells. Eur J Endocrinol142, 286—93.
39.
Willett, L.D., Huseman, C.A., Nelson, R.M., and Varma, M.M. (1987). Theophylline treatment in the neonate with apnea: effect on growth hormone, thyroid hormone and TRH induced TSH secretion. Dev Pharmacol Ther10, 73—80.
40.
Wolff, J., and Varrone, S. (1969). The methyl xanthines-anew class of goitrogens . Endocrinology85, 410—4.
